WILMINGTON, Del., Jan. 15, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, flouroproducts and chemical solutions, today reopened its newly renovated corporate headquarters in The DuPont Building, a registered historic landmark in downtown Wilmington, Delaware.
Chemours' return to the 106-year old building, now owned and operated by The Buccini/Pollin Group, comes after a 20-month renovation that has transformed its interior into a light-filled, modern, and elegant open workspace environment.
"Today we are renewing our commitment to this community as we begin the next chapter of our company's story in our beautifully renovated headquarters," said Chemours President and CEO Mark Vergnano. "This is a place that our team can be proud to call home. Our renovated office is a perfect metaphor for Chemours – a company grounded in its legacy, but transforming into an agile, innovative, and collaborative enterprise with a bias for action and growth."
Buccini/Pollin Group Co-President Christopher F. Buccini had this to say: "Chemours' decision to be based in this historic building is a fitting tribute to their heritage, while their 21st Century workspace points boldly to their future. We are proud to have been on this journey with them. They had other options, and we are grateful for their commitment to our city and our state."
Approximately 850 employees, contractors, and consultants will work in the company's new headquarters, which will occupy 280,000 square feet in 11 stories of the building. The newly renovated headquarters includes 50 tons of reclaimed marble that was kept out of landfills through Chemours' recapture and reclaim efforts. Each floor includes a unique space named "the oasis," including areas equipped with treadmills with laptop docking stations, product showcases, and living room-like lounges.
After considering other potential locations in the United States, Chemours chose Delaware, because of the area's highly educated workforce, close proximity to customers, and favorable changes to the state's corporate tax structure.
Today's ribbon cutting ceremony was attended by U.S. Senator Tom Carper, Delaware Governor John Carney, Wilmington Mayor Mike Purzycki, and more than 100 other local business and community leaders.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™. Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com, or follow us on Twitter @Chemours, or LinkedIn.
Forward Looking Statements
This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance, business plans, prospects, targets, goals and commitments, capital investments and projects, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, and our outlook for net sales, Adjusted EBITDA, Adjusted EPS, Free Cash Flow, and Return on Invested Capital (ROIC), all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2017. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.
Executive and Financial Communications Manager
VP, Corporate Development and Investor Relations
SOURCE The Chemours Company